Financials

  • Market Capitalization 215.58 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.34
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3537
NERV
Minerva Neurosciences, Inc - Common Stock
4.56 USD-5.79%-5.98%+15.44%+94.04%217.73 M USD
3542
TARA
Protara Therapeutics, Inc. - Common Stock
3.84 USD+0.52%-0.52%-2.54%+22.68%226.93 M USD
3572
KROS
Keros Therapeutics, Inc. - common stock
10.82 USD-1.90%-1.73%+6.50%-28.34%214.53 M USD
3576
GLSI
Greenwich LifeSciences, Inc. - Common stock
14.95 USD-4.59%-14.38%+10.74%+28.88%219.44 M USD

Noticias